UNLIMITED HEART
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

UNLIMITED HEART Trademark

Serial Number: 98062753

UNLIMITED HEART is a trademark filed by UNLIMITED HEART HEALTH AND WELLNESS, LLC on June 28, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

UNLIMITED HEART HEALTH AND WELLNESS, LLC (4 trademarks)

10 PARKER FARM LANE
AMHERST, NH 03031

Entity Type: 16

Unlimited Heart, LLC (3 trademarks)

10 Parker Farm Lane
Amherst, NH 03031

Entity Type: 16

Trademark Details

Filing Date

June 28, 2023

Registration Date

Not Registered

Published for Opposition

November 12, 2024

Goods & Services

Clinical research in the field of cardiovascular health; Cloud computing featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the field of cardiovascular disease and heart health; Medical and scientific research information in the field of cardiovascular disease and heart health; Scientific research for medical purposes in the field of cardiovascular disease and heart health; Software design and development; Software development in the field of digital therapeutics; Application service provider (ASP) featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Application service provider (ASP) featuring software for use providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Application service provider (ASP) featuring software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Application service provider (ASP) featuring software using artificial intelligence for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Creating an on-line community for heart disease patients; Platform as a service (PAAS) featuring computer software platforms for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Platform as a service (PAAS) featuring computer software platforms for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Providing information about medical research in the field of cardiovascular disease and heart health; Providing medical and scientific research information; Providing a website featuring non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring non-downloadable software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring resources, namely, non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring resources, namely, a website featuring primarily non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions and also featuring non-downloadable publications in the nature of articles in the field of cardiovascular disease and heart health; Providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical and scientific research; Providing on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing on-line non-downloadable software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing subscription-based temporary use of on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of non-downloadable cloud-based software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of a non-downloadable web application for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software and applications for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable cloud computing software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Smartphone software design; Software as a service (SAAS) services featuring software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Software as a service (SAAS) services featuring software for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Software as a service (SAAS) services featuring software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Software as a service (SAAS) services featuring software using artificial intelligence for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jun 24, 2026 EX3G
SOU EXTENSION 3 FILED
Jun 24, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 22, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 22, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 17, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 23, 2024 ERFR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 5, 2024 ASGN
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 21, 2024 GNFN
FINAL REFUSAL E-MAILED
Jun 21, 2024 GNFR
FINAL REFUSAL WRITTEN
Jun 21, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2023 NWOS
NEW APPLICATION ENTERED
Jul 1, 2023 NWAP